Analysis of the Clinical Effect of Combined Drug Susceptibility to Guide Medication for Carbapenem-Resistant Klebsiella pneumoniae Patients Based on the Kirby–Bauer Disk Diffusion Method

Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae

(2019) Dominika Ojdana et al.   Microbial Drug Resistance

Resistance reported from China antimicrobial surveillance network (CHINET) in 2018

(2019) Fupin Hu et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)

(2019) James A. Karlowsky et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections

(2019) Akosua A. Agyeman et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro

(2019) Jisheng Zhang et al.   Annals of Palliative Medicine

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

(2018) Romney M. Humphries et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis

(2018) Pin Liu et al.   Microbial Drug Resistance

Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China

(2018) Ling-bin Shu et al.   Infection and Drug Resistance

Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai

(2018) Dongxing Tian et al.   Infection and Drug Resistance

Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis

(2017) Philipp P. Kohler et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae

(2017) Liangfei Xu et al.   Annals of Clinical Microbiology and Antimicrobials

Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit

(2017) Xia Zheng et al.   Antimicrobial Resistance and Infection Control

Bloodstream infections caused byKlebsiella pneumoniaein onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey

(2016) Enrico Maria Trecarichi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Is combination therapy for carbapenem-resistantKlebsiella pneumoniaethe new standard of care?

(2015) Richard R Watkins et al.   Expert Review of Anti-Infective Therapy

Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection

(2015) Shujuan Ji et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance

(2014) D. van Duin et al.   CLINICAL MICROBIOLOGY AND INFECTION

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories

(2013) E. Matuschek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

(2013) David van Duin et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE